Vimarsana
Biggest News Aggregation in the World

Page 48 - Zai Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zai Lab Today - Breaking & Trending Today

Zai Lab (ZLAB) Scheduled to Post Quarterly Earnings on Monday - Vimarsana News

Zai Lab (ZLAB) Scheduled to Post Quarterly Earnings on Monday

Zai Lab (NASDAQ:ZLAB – Get Free Report) will announce its earnings results after the market closes on Monday, August 7th. Analysts expect the company to announce earnings of ($0.74) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Zai Lab (NASDAQ:ZLAB – Get […]

Source: wkrb13.com
Earnings Preview For Zai Lab - Zai Lab (NASDAQ:ZLAB) - Vimarsana News

Earnings Preview For Zai Lab - Zai Lab (NASDAQ:ZLAB)

Related Topics:
Zai Lab
Why Is Schrödinger Stock Tumbling Today? - Schrodinger (NASDAQ:SDGR) - Vimarsana News

Why Is Schrödinger Stock Tumbling Today? - Schrodinger (NASDAQ:SDGR)

Schrödinger Inc (NASDAQ: SDGR) shares are down after the company, on Wednesday, 

Related Topics:
Zai Lab LimitedZai Lab
Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings - Vimarsana News

Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings

Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 per Share on...

Head to Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN) and Immune Therapeutics (OTCMKTS:IMUN) - Vimarsana News

Head to Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN) and Immune Therapeutics (OTCMKTS:IMUN)

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Profitability This table compares Regeneron Pharmaceuticals and Immune […]

Source: wkrb13.com